Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 16 | 2020 | 505 | 2.420 |
Why?
|
| Smoking Cessation | 13 | 2020 | 211 | 2.250 |
Why?
|
| Ambulatory Care Facilities | 5 | 2020 | 84 | 1.220 |
Why?
|
| Health Services Accessibility | 7 | 2016 | 242 | 1.210 |
Why?
|
| Medicaid | 4 | 2012 | 101 | 0.970 |
Why?
|
| Poverty | 4 | 2018 | 105 | 0.930 |
Why?
|
| Medically Uninsured | 2 | 2016 | 35 | 0.830 |
Why?
|
| Tobacco Use Cessation | 3 | 2012 | 22 | 0.800 |
Why?
|
| Female | 49 | 2020 | 19945 | 0.790 |
Why?
|
| North Carolina | 18 | 2020 | 1300 | 0.780 |
Why?
|
| Survivors | 3 | 2012 | 173 | 0.770 |
Why?
|
| Humans | 62 | 2020 | 32282 | 0.710 |
Why?
|
| Health Behavior | 5 | 2018 | 211 | 0.700 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 219 | 0.690 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 180 | 0.680 |
Why?
|
| Mass Screening | 4 | 2019 | 256 | 0.660 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2018 | 316 | 0.660 |
Why?
|
| Students | 4 | 2017 | 174 | 0.650 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 423 | 0.640 |
Why?
|
| Foster Home Care | 1 | 2020 | 4 | 0.630 |
Why?
|
| Community Health Centers | 1 | 2020 | 12 | 0.620 |
Why?
|
| Male | 38 | 2020 | 19441 | 0.610 |
Why?
|
| Hungary | 8 | 2019 | 14 | 0.600 |
Why?
|
| Early Detection of Cancer | 5 | 2020 | 100 | 0.580 |
Why?
|
| Adolescent Behavior | 6 | 2019 | 64 | 0.580 |
Why?
|
| Adolescent | 18 | 2020 | 3519 | 0.570 |
Why?
|
| Attitude to Health | 3 | 2019 | 138 | 0.560 |
Why?
|
| Cross-Sectional Studies | 13 | 2020 | 1479 | 0.560 |
Why?
|
| Middle Aged | 27 | 2020 | 11851 | 0.550 |
Why?
|
| Intention | 2 | 2017 | 30 | 0.550 |
Why?
|
| Adult | 22 | 2020 | 9259 | 0.540 |
Why?
|
| Breast Neoplasms | 4 | 2006 | 762 | 0.500 |
Why?
|
| Ambulatory Care | 3 | 2019 | 112 | 0.490 |
Why?
|
| Tobacco Use Disorder | 3 | 2012 | 90 | 0.470 |
Why?
|
| Mothers | 2 | 2016 | 74 | 0.470 |
Why?
|
| Pregnancy Outcome | 2 | 2012 | 86 | 0.440 |
Why?
|
| Hispanic Americans | 6 | 2019 | 772 | 0.420 |
Why?
|
| Prenatal Care | 2 | 2012 | 54 | 0.420 |
Why?
|
| Aged | 18 | 2020 | 10263 | 0.410 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 183 | 0.380 |
Why?
|
| Uncompensated Care | 1 | 2012 | 4 | 0.370 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 12 | 0.370 |
Why?
|
| United States | 16 | 2020 | 4072 | 0.370 |
Why?
|
| Retrospective Studies | 8 | 2019 | 3626 | 0.370 |
Why?
|
| Needs Assessment | 2 | 2012 | 78 | 0.370 |
Why?
|
| Alcohol Drinking | 4 | 2012 | 255 | 0.360 |
Why?
|
| Colonoscopy | 1 | 2012 | 45 | 0.360 |
Why?
|
| Curriculum | 4 | 2009 | 203 | 0.360 |
Why?
|
| Ethnic Groups | 3 | 2019 | 450 | 0.350 |
Why?
|
| Clinical Competence | 2 | 2006 | 330 | 0.350 |
Why?
|
| Insurance Coverage | 1 | 2012 | 80 | 0.350 |
Why?
|
| Premature Birth | 1 | 2012 | 73 | 0.340 |
Why?
|
| Pregnant Women | 1 | 2011 | 6 | 0.340 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 43 | 0.340 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 70 | 0.330 |
Why?
|
| Romania | 6 | 2020 | 6 | 0.320 |
Why?
|
| Neoplasms | 3 | 2020 | 754 | 0.320 |
Why?
|
| Risk Factors | 12 | 2018 | 3934 | 0.320 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 187 | 0.320 |
Why?
|
| Prisons | 1 | 2010 | 5 | 0.320 |
Why?
|
| Social Control Policies | 1 | 2010 | 3 | 0.320 |
Why?
|
| SEER Program | 1 | 2010 | 38 | 0.320 |
Why?
|
| Body Weight | 1 | 2012 | 323 | 0.320 |
Why?
|
| Organizational Policy | 1 | 2010 | 20 | 0.320 |
Why?
|
| Public Health Practice | 1 | 2010 | 8 | 0.310 |
Why?
|
| Life Style | 1 | 2012 | 393 | 0.310 |
Why?
|
| Counseling | 4 | 2019 | 93 | 0.300 |
Why?
|
| Health Policy | 1 | 2010 | 89 | 0.300 |
Why?
|
| Psychometrics | 3 | 2006 | 137 | 0.290 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 444 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 158 | 0.290 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 17 | 0.280 |
Why?
|
| Pregnancy | 4 | 2018 | 961 | 0.280 |
Why?
|
| Faculty, Medical | 2 | 2006 | 76 | 0.280 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2018 | 38 | 0.270 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 1076 | 0.270 |
Why?
|
| Internet | 5 | 2019 | 202 | 0.270 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 83 | 0.270 |
Why?
|
| Age Factors | 4 | 2012 | 1179 | 0.270 |
Why?
|
| Young Adult | 6 | 2020 | 2649 | 0.260 |
Why?
|
| Decision Making | 2 | 2019 | 189 | 0.260 |
Why?
|
| Health Care Surveys | 4 | 2020 | 184 | 0.260 |
Why?
|
| African Americans | 6 | 2019 | 1335 | 0.260 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 39 | 0.250 |
Why?
|
| Mastectomy, Segmental | 1 | 2006 | 25 | 0.240 |
Why?
|
| Logistic Models | 5 | 2018 | 743 | 0.240 |
Why?
|
| Quality of Life | 3 | 2006 | 964 | 0.240 |
Why?
|
| Socioeconomic Factors | 6 | 2016 | 388 | 0.240 |
Why?
|
| Mutation | 2 | 2017 | 497 | 0.220 |
Why?
|
| Prevalence | 5 | 2020 | 955 | 0.220 |
Why?
|
| Health Promotion | 4 | 2012 | 242 | 0.210 |
Why?
|
| Interview, Psychological | 1 | 2003 | 9 | 0.190 |
Why?
|
| Patient Simulation | 1 | 2003 | 29 | 0.190 |
Why?
|
| Problem-Based Learning | 1 | 2003 | 29 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2020 | 178 | 0.190 |
Why?
|
| Education, Medical | 1 | 2003 | 69 | 0.180 |
Why?
|
| Self Concept | 1 | 2002 | 45 | 0.170 |
Why?
|
| HIV Infections | 2 | 2019 | 450 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2018 | 1840 | 0.160 |
Why?
|
| Caregivers | 1 | 2002 | 114 | 0.160 |
Why?
|
| Advance Care Planning | 1 | 2019 | 15 | 0.150 |
Why?
|
| Preventive Health Services | 1 | 2020 | 39 | 0.150 |
Why?
|
| Peer Group | 3 | 2018 | 47 | 0.150 |
Why?
|
| Documentation | 1 | 2019 | 39 | 0.150 |
Why?
|
| Health Services | 1 | 2019 | 40 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 90 | 0.150 |
Why?
|
| Interviews as Topic | 3 | 2010 | 194 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2020 | 205 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2012 | 863 | 0.150 |
Why?
|
| Access to Information | 1 | 2019 | 13 | 0.150 |
Why?
|
| Program Evaluation | 3 | 2010 | 171 | 0.140 |
Why?
|
| Program Development | 2 | 2012 | 93 | 0.140 |
Why?
|
| Telemedicine | 1 | 2020 | 122 | 0.140 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2018 | 2 | 0.140 |
Why?
|
| Tobacco | 1 | 2019 | 43 | 0.140 |
Why?
|
| Antitubercular Agents | 1 | 2018 | 7 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2018 | 17 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 179 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2018 | 456 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 130 | 0.130 |
Why?
|
| Child | 2 | 2016 | 2435 | 0.130 |
Why?
|
| Multimedia | 1 | 2017 | 19 | 0.130 |
Why?
|
| Canada | 1 | 2017 | 63 | 0.130 |
Why?
|
| Universities | 2 | 2016 | 149 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2017 | 23 | 0.130 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 52 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2016 | 666 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2011 | 553 | 0.130 |
Why?
|
| Schools | 1 | 2017 | 65 | 0.130 |
Why?
|
| Educational Status | 2 | 2019 | 167 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 2240 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 180 | 0.120 |
Why?
|
| Crime Victims | 2 | 2008 | 10 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 651 | 0.120 |
Why?
|
| Physician Executives | 1 | 2016 | 12 | 0.120 |
Why?
|
| Students, Medical | 2 | 2009 | 126 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2009 | 75 | 0.120 |
Why?
|
| Mammography | 2 | 2006 | 41 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 189 | 0.110 |
Why?
|
| Schools, Medical | 3 | 2006 | 43 | 0.110 |
Why?
|
| Social Environment | 2 | 2012 | 74 | 0.100 |
Why?
|
| Ovulation Inhibition | 1 | 2013 | 1 | 0.100 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2013 | 6 | 0.100 |
Why?
|
| Infertility, Female | 1 | 2013 | 6 | 0.100 |
Why?
|
| Health Personnel | 1 | 2015 | 112 | 0.100 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2013 | 30 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2020 | 2316 | 0.100 |
Why?
|
| Risk-Taking | 3 | 2011 | 96 | 0.100 |
Why?
|
| Comorbidity | 2 | 2013 | 565 | 0.100 |
Why?
|
| Infant | 1 | 2016 | 1010 | 0.090 |
Why?
|
| Maternal-Child Health Centers | 1 | 2012 | 4 | 0.090 |
Why?
|
| Maternal Age | 1 | 2012 | 13 | 0.090 |
Why?
|
| Biometry | 1 | 2012 | 14 | 0.090 |
Why?
|
| Virginia | 1 | 2012 | 55 | 0.090 |
Why?
|
| Health Surveys | 3 | 2008 | 175 | 0.090 |
Why?
|
| Inservice Training | 1 | 2012 | 12 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2016 | 1233 | 0.090 |
Why?
|
| Environment | 1 | 2012 | 47 | 0.090 |
Why?
|
| Body Image | 1 | 2012 | 19 | 0.090 |
Why?
|
| Physician-Patient Relations | 2 | 2004 | 179 | 0.090 |
Why?
|
| Heterosexuality | 1 | 2011 | 15 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 120 | 0.090 |
Why?
|
| Condoms | 1 | 2011 | 34 | 0.090 |
Why?
|
| Data Collection | 2 | 2010 | 171 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 907 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 212 | 0.080 |
Why?
|
| Rural Population | 2 | 2010 | 216 | 0.080 |
Why?
|
| Mexico | 2 | 2011 | 47 | 0.080 |
Why?
|
| Parents | 1 | 2012 | 151 | 0.080 |
Why?
|
| Survival Rate | 1 | 2012 | 893 | 0.080 |
Why?
|
| Patient Selection | 2 | 2019 | 272 | 0.080 |
Why?
|
| Patient Participation | 2 | 2020 | 90 | 0.070 |
Why?
|
| Emigrants and Immigrants | 1 | 2011 | 198 | 0.070 |
Why?
|
| Lung | 2 | 2020 | 263 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2009 | 32 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 461 | 0.070 |
Why?
|
| United States Public Health Service | 1 | 2008 | 3 | 0.070 |
Why?
|
| Courtship | 1 | 2008 | 4 | 0.070 |
Why?
|
| Prognosis | 1 | 2012 | 1534 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 161 | 0.070 |
Why?
|
| Community Health Services | 1 | 2007 | 47 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 132 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 2008 | 140 | 0.060 |
Why?
|
| New Hampshire | 1 | 2006 | 4 | 0.060 |
Why?
|
| Boston | 1 | 2006 | 16 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2006 | 245 | 0.060 |
Why?
|
| Life Change Events | 1 | 2006 | 20 | 0.060 |
Why?
|
| Mastectomy | 1 | 2006 | 59 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1111 | 0.060 |
Why?
|
| Training Support | 1 | 2006 | 6 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 86 | 0.060 |
Why?
|
| Women's Health Services | 1 | 2006 | 10 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 25 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2006 | 32 | 0.060 |
Why?
|
| Vaginal Smears | 1 | 2006 | 9 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2006 | 19 | 0.060 |
Why?
|
| Feedback | 1 | 2006 | 41 | 0.060 |
Why?
|
| Law Enforcement | 1 | 2006 | 27 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 42 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2006 | 341 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 395 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2006 | 477 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2006 | 217 | 0.060 |
Why?
|
| Rape | 1 | 2004 | 2 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2004 | 11 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 555 | 0.050 |
Why?
|
| Indians, North American | 1 | 2004 | 75 | 0.050 |
Why?
|
| Women's Health | 1 | 2006 | 230 | 0.050 |
Why?
|
| Sex Factors | 1 | 2006 | 655 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 381 | 0.050 |
Why?
|
| Trust | 1 | 2004 | 43 | 0.050 |
Why?
|
| Family Practice | 1 | 2004 | 49 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 332 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 3900 | 0.050 |
Why?
|
| Minerals | 1 | 2003 | 14 | 0.050 |
Why?
|
| Community Medicine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2006 | 458 | 0.050 |
Why?
|
| Vitamins | 1 | 2003 | 71 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 231 | 0.050 |
Why?
|
| Health Facility Environment | 1 | 2002 | 1 | 0.050 |
Why?
|
| Interior Design and Furnishings | 1 | 2002 | 1 | 0.050 |
Why?
|
| Teaching | 1 | 2002 | 60 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2003 | 113 | 0.050 |
Why?
|
| Nursing Homes | 1 | 2002 | 33 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2004 | 232 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2003 | 188 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2002 | 40 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2002 | 72 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 1425 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 2205 | 0.040 |
Why?
|
| Confidentiality | 1 | 2020 | 31 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 757 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2004 | 319 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 18 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 820 | 0.040 |
Why?
|
| HIV | 1 | 2019 | 26 | 0.040 |
Why?
|
| Computers, Handheld | 1 | 2019 | 15 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2019 | 9 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2020 | 62 | 0.040 |
Why?
|
| Consumer Health Information | 1 | 2019 | 15 | 0.040 |
Why?
|
| Health Status | 1 | 2002 | 355 | 0.040 |
Why?
|
| Terminal Care | 1 | 2019 | 25 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Dementia | 1 | 2002 | 246 | 0.040 |
Why?
|
| Income | 1 | 2019 | 66 | 0.040 |
Why?
|
| Hypertension | 1 | 2006 | 979 | 0.040 |
Why?
|
| Serbia | 1 | 2018 | 4 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 167 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 54 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 179 | 0.040 |
Why?
|
| Religion | 1 | 2018 | 28 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 219 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 413 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2018 | 60 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 308 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 15 | 0.030 |
Why?
|
| Genes, erbB-1 | 1 | 2017 | 14 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 35 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 17 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2017 | 22 | 0.030 |
Why?
|
| Genes, ras | 1 | 2017 | 26 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 81 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 90 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 96 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 854 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 146 | 0.030 |
Why?
|
| Incidence | 2 | 2013 | 1241 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 315 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 757 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 591 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2004 | 273 | 0.030 |
Why?
|
| Causality | 1 | 2013 | 37 | 0.030 |
Why?
|
| Age Distribution | 1 | 2013 | 194 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 595 | 0.020 |
Why?
|
| Acculturation | 1 | 2011 | 15 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2011 | 114 | 0.020 |
Why?
|
| Health Education | 1 | 2011 | 149 | 0.020 |
Why?
|
| Employment | 1 | 2009 | 44 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2008 | 38 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2008 | 56 | 0.020 |
Why?
|
| Public Health | 1 | 2007 | 91 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2008 | 130 | 0.020 |
Why?
|
| Budgets | 1 | 2006 | 10 | 0.010 |
Why?
|
| Financing, Organized | 1 | 2006 | 17 | 0.010 |
Why?
|
| Benchmarking | 1 | 2006 | 24 | 0.010 |
Why?
|
| Police | 1 | 2006 | 26 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 287 | 0.010 |
Why?
|
| Commerce | 1 | 2006 | 69 | 0.010 |
Why?
|
| Contraception | 1 | 2004 | 11 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 120 | 0.010 |
Why?
|
| Infection Control | 1 | 2003 | 26 | 0.010 |
Why?
|
| Communication | 1 | 2004 | 128 | 0.010 |
Why?
|
| Religion and Medicine | 1 | 2003 | 18 | 0.010 |
Why?
|
| Tobacco, Smokeless | 1 | 2002 | 14 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 73 | 0.010 |
Why?
|
| Maintenance | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lighting | 1 | 2002 | 5 | 0.010 |
Why?
|
| Noise | 1 | 2002 | 7 | 0.010 |
Why?
|
| Privacy | 1 | 2002 | 9 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2002 | 76 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2002 | 83 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 65 | 0.010 |
Why?
|
| Observer Variation | 1 | 2002 | 96 | 0.010 |
Why?
|
| Goals | 1 | 2002 | 34 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 565 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 245 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 1437 | 0.010 |
Why?
|